Holen Sie sich die Stockscreener-App
26.91
9.84%
2.41
Schlusskurs vom Vortag:
$24.50
Offen:
$24.87
24-Stunden-Volumen:
683.05K
Relative Volume:
0.44
Marktkapitalisierung:
$2.01B
Einnahmen:
$254.91M
Nettoeinkommen (Verlust:
$-103.48M
KGV:
-19.17
EPS:
-1.4036
Netto-Cashflow:
$-148.35M
1W Leistung:
+15.00%
1M Leistung:
-6.72%
6M Leistung:
+129.22%
1J Leistung:
+21.38%
1-Tages-Spanne:
$24.50
$27.04
1-Wochen-Bereich:
$22.01
$24.89
52-Wochen-Spanne:
$10.95
$33.78
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
26.91 | 2.01B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
313.23 | 50.71B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
71.83 | 13.09B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
58.58 | 11.59B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
112.84 | 9.11B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
102.07 | 8.44B | 1.34B | 230.70M | 440.96M | 2.6695 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-14 | Fortgesetzt | UBS | Neutral |
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrödinger to Announce Third Quarter 2026 Financial Results on November 4 - Business Wire
Certara, Inc. (CERT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Up to 40% of lithium ions in battery fluid cluster. This could help guide battery design. - Stock Titan
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains? - Zacks Investment Research
Global Drug Discovery AI Tools MarketStrategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities - GlobeNewswire Inc.
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Early Warning Disclosure Regarding Common Shares of Irruptive Metals Corp. - Yahoo Finance
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com Nigeria
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com South Africa
Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com India
Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan
Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing - Yahoo Finance
Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com
Schrodinger Inc. (SDGR) Pulls Back 4.03% to $29.02, Nearing Key SupportCharm Flow - dars.gov.et
Host Digital Inc. Announces Common Stock Offering - Yahoo Finance
Insider at Schrodinger (NASDAQ: SDGR) plans September 2026 stock sale - Stock Titan
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Schrödinger Stock Adds 26% and $472 Million of Market Value; Tectora’s Terms Stay Private - TechStock²
Understanding the Setup: (SDGR) and Scalable Risk - Stock Traders Daily
Schrödinger introduces Tectora Therapeutics - BioWorld News
Tectora Therapeutics inc. announced that it has received $55 million in funding from New Enterprise Associates, Inc., RA Capital Management, L.P., Schrödinger, Inc. - marketscreener.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - BioSpace
SDGR Looks 19.2% Undervalued on GF Value™ - GuruFocus
Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates - marketscreener.com
A new drug company raises $55 million for oral medicines - Stock Titan
Is Schrodinger Inc (SDGR) a Bargain After 3.1% Drop? GF Value Sa - GuruFocus
Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportPut Flow Alert - dars.gov.et
Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportUp Down Volume - vinanet.vn
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook? - TradingView
“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty - Yahoo Finance
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - PR Newswire
Schrödinger’s Strait - الحرة
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Drug Discovery Platforms Market to Reach USD 16.5 Billion by 2036, Driven by AI-Powered Research and Rising Pharmaceutical R&D Investment - industrytoday.co.uk
Schrödinger to Present at Morgan Stanley Global Healthcare Conference 2026 - BioSpace
Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire
Schrodinger Inc. (SDGR) Slips 1.81% to $20.04 as Stock Holds Above Key SupportInsider Selling Alerts - dars.gov.et
SDGR | Schrodinger, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Schrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR) - Seeking Alpha
Tejara Capital Ltd Takes $4.55 Million Position in Schrodinger, Inc. $SDGR - MarketBeat
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript - AOL.ca
Schrodinger (NASDAQ:SDGR) Trading 10.4% HigherWhat's Next? - MarketBeat
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24 - Moomoo
Schrodinger Inc (SDGR) News, Articles, Events & Latest Updates - Stocktwits
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Zacks Investment Research
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - Yahoo Finance
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci - The Globe and Mail
Schrödinger-BMS collaboration centers on Bunsen for trillion-scale computational drug discovery - drugdiscoverytrends.com
Schrodinger Inc. (SDGR) Slides 4.7% to $17.59 as Bearish Momentum BuildsCounter Trend Trade - Vinanet
SDGR Looks 29.7% Undervalued on GF Value™ - GuruFocus
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Schrodinger Inc-Aktie (SDGR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | See Remarks |
Sep 17 '26 |
Sale |
29.37 |
31,599 |
927,970 |
69,956 |
| KAREN OLUFUNMILYO AKINSANYA-AK | Officer |
Sep 17 '26 |
Proposed Sale |
23.93 |
31,599 |
756,164 |
0 |
| Jain Rachit | EVP & CFO |
Jul 16 '26 |
Sale |
15.60 |
875 |
13,647 |
50,877 |
| Jain Rachit | Officer |
Jul 16 '26 |
Proposed Sale |
15.60 |
875 |
13,647 |
0 |
| Aklian Mannix Vartan | Officer |
Jul 01 '26 |
Proposed Sale |
16.68 |
1,136 |
18,949 |
0 |
| Herman Jenny | Officer |
May 01 '26 |
Proposed Sale |
12.26 |
1,957 |
24,000 |
0 |
| Farid Ramy | President & CEO |
Apr 17 '26 |
Option Exercise |
3.07 |
117,527 |
360,808 |
405,351 |
| Farid Ramy | President & CEO |
Apr 17 '26 |
Sale |
12.21 |
43,000 |
524,944 |
330,824 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Option Exercise |
3.07 |
43,000 |
132,010 |
373,824 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Sale |
12.33 |
43,000 |
530,233 |
330,824 |
0.87%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):